Royce & Associates’s Douglas Elliman DOUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,488
Closed -$46.3K 884
2023
Q3
$46.3K Sell
20,488
-75,798
-79% -$174K ﹤0.01% 905
2023
Q2
$214K Sell
96,286
-117,991
-55% -$324K ﹤0.01% 881
2023
Q1
$635K Sell
214,277
-83,989
-28% -$335K 0.01% 822
2022
Q4
$1.16M Buy
298,266
+105,122
+54% +$419K 0.01% 734
2022
Q3
$754K Buy
193,144
+105,550
+120% +$521K 0.01% 778
2022
Q2
$400K Buy
+87,594
New +$485K ﹤0.01% 858
2022
Q1
Sell
-11,591
Closed -$127K 977
2021
Q4
$127K Buy
+11,591
New +$130K ﹤0.01% 955

Other funds holding DOUG

Royce & Associates's DOUG Position: Q4 2023 in Review

Royce & Associates sold out of Douglas Elliman (DOUG) in Q4 2023, closing a stake of 20,488 shares — an estimated $46.3K sold.

Royce & Associates first reported a position in DOUG in Q4 2021 and held it in 7 quarters. The position peaked at $1.16M in Q4 2022. 151 funds tracked by Wall St. Rank hold DOUG as of Q4 2023.

  • Royce & Associates reported no remaining Douglas Elliman position as of Q4 2023 after selling out during the quarter.
  • Royce & Associates sold 20,488 Douglas Elliman shares in Q4 2023, an estimated $46.3K.
  • Royce & Associates first reported a position in Douglas Elliman in Q4 2021 and held it in 7 quarters.
  • Royce & Associates's Douglas Elliman position peaked at $1.16M in Q4 2022.
  • 151 funds tracked by Wall St. Rank held Douglas Elliman as of Q4 2023.

Based on Royce & Associates's 13F filing for Q4 2023, filed 12 Feb 2024.